methotrexate has been researched along with Graves Ophthalmopathy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| El Essawy, RA; Elessawy, KB; Nasr, HE; Swaify, IY | 1 |
| Aghazadeh, H; Rubinov, A; Weis, E; Zommer, H | 1 |
| David, J; Insull, EA; Keren, S; Norris, JH; Sipkova, Z; Turner, HE | 1 |
| Genere, N; Stan, MN | 1 |
| Murthy, R; Roos, JCP | 1 |
| Andrei, S; Enache, V; Renetti, A; Spiroiu, C; Zemba, M; Zugravu, V | 1 |
2 review(s) available for methotrexate and Graves Ophthalmopathy
| Article | Year |
|---|---|
Current and Emerging Treatment Strategies for Graves' Orbitopathy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunotherapy; Methotrexate; Mycophenolic Acid; Rituximab; Selenium; Severity of Illness Index | 2019 |
Update on the clinical assessment and management of thyroid eye disease.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Decompression, Surgical; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sirolimus | 2019 |
1 trial(s) available for methotrexate and Graves Ophthalmopathy
| Article | Year |
|---|---|
Periocular methotrexate versus periocular triamcinolone injections for active thyroid-associated orbitopathy: a randomized clinical trial.
Topics: Exophthalmos; Graves Ophthalmopathy; Humans; Injections, Intraocular; Methotrexate; Prospective Studies; Treatment Outcome; Triamcinolone | 2023 |
3 other study(ies) available for methotrexate and Graves Ophthalmopathy
| Article | Year |
|---|---|
Role of methotrexate in thyroid-related orbitopathy.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Injections, Intravenous; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome | 2018 |
Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Aged; Aged, 80 and over; Female; Graves Ophthalmopathy; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Retrospective Studies | 2018 |
[Treatment of thyroid ophthalmopathy--a clinical case].
Topics: Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Nicergoline; Optic Nerve Diseases; Risk Factors; Smoking; Treatment Outcome; Vasodilator Agents; Visual Field Tests; Vitamin B Complex | 2007 |